.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Understanding cochlear implant research attrition is essential for maintaining the integrity of long-term clinical trials and improving patient outcomes. A recent retrospective review examined why adult cochlear implant (CI) recipients withdraw from repeated-measures studies. Researchers analyzed a sample of 118 participants to identify sociodemographic and audiologic factors associated with study completion. Consequently, the findings provide a roadmap for enhancing participant retention in future clinical investigations.
The study identified a 21% attrition rate over a 12-month period. Interestingly, sociodemographic factors such as age, race, biological sex, and socioeconomic position were similar between the groups. However, audiologic differences were significant. Specifically, participants in the withdrawal group demonstrated poorer low-frequency acoustic hearing thresholds. Furthermore, they experienced greater tonotopic mismatch compared to those who completed the research. These results suggest that baseline audiologic status may predict a participant's ability or willingness to adhere to rigorous research protocols.
Early clinical performance emerged as a primary driver of retention. Participants who remained in the study achieved significantly higher early CNC word recognition scores than those who dropped out. Therefore, patients who perceive a faster or greater initial benefit from their device are more likely to stay engaged. Additionally, individuals using electric-acoustic stimulation (EAS) were more persistent than those using CI alone. This trend likely reflects the better unaided thresholds and performance advantages inherent in EAS technology. Researchers must account for these performance disparities when designing study inclusion criteria.
To reduce cochlear implant research attrition, clinicians and researchers must reflect on these withdrawal patterns. Intentionally designing study procedures that support a representative sample is crucial. Moreover, providing additional support or more flexible scheduling for those with poorer early speech recognition may improve retention rates. Addressing these barriers ensures that clinical research remains inclusive and the data remains representative of the broader CI population.
Recent data indicates an attrition rate of approximately 21% in long-term, repeated-measures clinical research involving cochlear implant recipients. Identifying those at risk of withdrawal early is key to maintaining study power.
Participants with poorer low-frequency acoustic hearing and higher tonotopic mismatch are significantly more likely to leave a study. These variables often correlate with overall satisfaction and device use time.
Early performance is a strong predictor of persistence. Participants with better initial CNC word recognition scores are more likely to complete long-term research than those who struggle early on.
Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or a substitute for professional healthcare consultation. Always seek the advice of a qualified health provider regarding medical conditions. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A retrospective review identifies audiologic and performance variables as key drivers of participant attrition in long-term cochlear implant research....
6 months ago
A clinical comparison of extravascular and subcutaneous implantable cardioverter-defibrillators, detailing patient selection, pacing capabilities, and implantation nuances.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
